Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed

Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed

Steven F Powell1, Arkadiusz Z Dudek21Department of Medicine, University of Minnesota, Minneapolis, MN, USA; 2Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USAAbstract: Pemetrexed (ALIMTA, LY231514, MTA) is a novel multitargeted antifolate that is cur...

Full description

Bibliographic Details
Main Authors:	Steven F Powell, Arkadiusz Z Dudek
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-06-01
Series:	Pharmacogenomics and Personalized Medicine
Online Access:	http://www.dovepress.com/tailoring-treatment-of-nonsmall-cell-lung-cancer-by-tissue-type-role-o-a3290

Similar Items

Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer
by: Liang Ye, et al.
Published: (2017-01-01)

Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
by: Gee-Chen Chang, et al.
Published: (2013-09-01)

Nonsmall cell lung cancer
by: Jean-Paul Sculier
Published: (2013-03-01)

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis
by: Zhonghan Zhang, et al.
Published: (2019-12-01)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
by: Christopher M. Kniese, et al.
Published: (2020-11-01)

Effectiveness of maintenance treatments for nonsmall cell lung cancer
by: Eadens MJ, et al.
Published: (2011-07-01)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
by: Luca Toschi, et al.
Published: (2009-08-01)

The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer
by: Mauricio Escobar, et al.
Published: (2011-01-01)

The role of galectin-3 in nonsmall cell lung cancer
by: Vuong, Lynda
Published: (2016)

Surgery for nonsmall cell lung cancer
by: Loïc Lang-Lazdunski
Published: (2013-09-01)

Update on nonsmall cell lung cancer
by: G. Zalcman, et al.
Published: (2010-09-01)

Role of gender in the survival of surgical patients with nonsmall cell lung cancer
by: Nóris C Scaglia, et al.
Published: (2013-01-01)

Personalised medicine for nonsmall cell lung cancer
by: Céline Mascaux, et al.
Published: (2017-11-01)

Ceritinib in the treatment of ALK-positive patients with nonsmall-cell lung cancer
by: K. K. Laktionov, et al.
Published: (2019-06-01)

Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer
by: Cesare Gridelli, et al.
Published: (2011-01-01)

Endobronchial ultrasound in the management of nonsmall cell lung cancer
by: Christophe Dooms, et al.
Published: (2013-06-01)

An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
by: Nan Zhao, et al.
Published: (2015-01-01)

TP53 Mutations in Nonsmall Cell Lung Cancer
by: Akira Mogi, et al.
Published: (2011-01-01)

Thyroid Metastasis from Nonsmall Cell Lung Cancer
by: Tariq Namad, et al.
Published: (2013-01-01)

Importance of dose intensity in treatment of advanced nonsmall cell lung cancer in the elderly
by: Narayanan Prasad, et al.
Published: (2012-07-01)

Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer
by: Pamela Abdayem, et al.
Published: (2021-07-01)

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
by: Lin Z, et al.
Published: (2017-11-01)

Pemetrexed-induced organizing pneumonia in the treatment of lung adenocarcinoma
by: N. China-Pereira, et al.
Published: (2017-11-01)

The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer
by: Alexandra Pender, et al.
Published: (2015-06-01)

Pattern of bone metastasis in patients with nonsmall cell lung cancer
by: Kunihiko Miyazaki, et al.
Published: (2018-01-01)

Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
by: Takao Hiraki, et al.
Published: (2014-01-01)

Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
by: Daniel R. Gomez, et al.
Published: (2012-01-01)

Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
by: Lucio Crinò, et al.
Published: (2014-03-01)

Disparate outcomes in nonsmall cell lung cancer by immigration status
by: Brittney Chau, et al.
Published: (2021-04-01)

How to handle oligometastatic disease in nonsmall cell lung cancer
by: Florian Eichhorn, et al.
Published: (2021-01-01)

Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity
by: Cobo M, et al.
Published: (2017-07-01)

The role of clusterin in nonsmall cell lung cancer cells against TRAIL-induced apoptosis
by: Mei-Hong, et al.
Published: (2010)

Intraventricular chemotherapy and nonsmall cell lung carcinoma
by: Jamir Pitton Rissardo, et al.
Published: (2019-01-01)

Comparing African- and U.S.-Born Blacks at Stage of Diagnosis and Treatment for Nonsmall Cell Lung Cancer
by: Fofung, Relindis K.
Published: (2016)

Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients with Nonsmall Cell Lung Cancer
by: Jie-Yao Li, et al.
Published: (2014-01-01)

Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
by: Minami S, et al.
Published: (2015-01-01)

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
by: J Greenhalgh, et al.
Published: (2010-10-01)

The diagnostic role of microRNA 21 in patients with nonsmall cell lung cancer: An exploratory study
by: Shreyash Rai, et al.
Published: (2020-01-01)

Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer
by: Ying Sun, et al.
Published: (2015-01-01)

Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer
by: Nozomu Motono, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_srljj8q5s0jovdpajeap88m9k2